CIRÈLL Nasıl Kullanılır? Adım Adım Uygulama Protokolü

How to Use CIRÈLL: A Step-by-Step Application Protocol

CIRÈLL dermocosmetic products are designed to repair and strengthen the skin barrier, applied following a specific sequence in both morning and evening routines — cleanse, tone, active serum, then barrier cream.

Key Findings

  • CIRÈLL's Biomimetic TriBarrier System combines ceramide NP/AP/EOS, cholesterol, and essential fatty acids at a physiological 1:1:1 molar ratio, directly reflecting the stratum corneum's own natural lamellar lipid matrix.
  • As a general rule, CIRÈLL barrier cream is used twice daily, morning and evening; a third application after handwashing or showering may be reasonable for very dry, atopic, or significantly barrier-compromised skin.
  • A pea-sized amount (approximately 0.5 mL) per application represents a reasonable general guideline.
  • CIRÈLL barrier cream is fully compatible with niacinamide, hyaluronic acid, panthenol, madecassoside, and ectoin; with retinol or AHA/BHA actives, a 'sandwiching' technique — thin barrier cream layer, then retinol, then another thin barrier cream layer — can help reduce irritation risk.

What Distinguishes CIRÈLL from Ordinary Moisturizers

Rather than providing only surface-level moisturizing, CIRÈLL works through the Biomimetic TriBarrier System, which mimics the skin's own lipid structure. Ordinary moisturizers typically contain water and a single type of emollient, while CIRÈLL formulations bring together ceramide NP/AP/EOS, cholesterol, and essential fatty acids at a physiological 1:1:1 molar ratio. Because this ratio directly reflects the stratum corneum's natural lamellar lipid matrix, barrier repair occurs at a structural level, not merely a superficial one.

How to Use CIRÈLL: A Step-by-Step Application Protocol | CIRÈLL
How to Use CIRÈLL: A Step-by-Step Application Protocol

How CIRÈLL's Mechanism Works

The biomimetic lipid complex in CIRÈLL supplies ceramide, cholesterol, and linoleic acid in physiological proportion to a damaged or deficient stratum corneum lamellar structure. These components serve as the "mortar" holding keratinocyte layers together, reducing transepidermal water loss (TEWL), limiting irritant penetration, and suppressing inflammatory cytokine release. In clinical studies of similar biomimetic lipid formulations, four weeks of use has been shown to reduce TEWL by an average of approximately 47%.

Morning Routine: Step-by-Step

The general morning sequence is: gentle cleanser, followed optionally by an antioxidant serum, then CIRÈLL barrier cream, and finally SPF 50 as the final step — consistent with the thinnest-to-thickest layering principle and the essential role of daytime photoprotection discussed extensively throughout this literature.

Evening Routine: Repair and Regeneration

The evening sequence is: double cleansing, followed by any active serum (retinoid, niacinamide, or peptide), then CIRÈLL barrier cream as the final step — aligning with the nighttime repair biology discussed extensively elsewhere in this literature, allowing the barrier cream to support structural repair during this period of heightened cellular activity.

Frequency, Amount, and Active-Ingredient Combination

As a general rule, CIRÈLL barrier cream is used twice daily; individuals with very dry, atopic, or significantly barrier-compromised skin may reasonably add a third application after handwashing or showering, while oilier skin types may find a lighter morning layer and a richer evening layer sufficient. A pea-sized amount (approximately 0.5 mL) per application represents a reasonable general guideline. CIRÈLL barrier cream is fully compatible with niacinamide, hyaluronic acid, panthenol, madecassoside, and ectoin. With retinol or AHA/BHA actives, rather than applying them in the same layer, a "sandwiching" technique — thin barrier cream, then retinol, then another thin barrier cream layer — can help reduce irritation risk. High-concentration vitamin C serums (L-ascorbic acid, pH below 3.5) should be allowed to fully absorb before CIRÈLL cream is applied; the two products should not be mixed directly.

Frequency, Amount, and Active-Ingredient Combination | CIRÈLL
Frequency, Amount, and Active-Ingredient Combination

Suitability for Sensitive and Reactive Skin

CIRÈLL formulations were developed without fragrance or common irritants, and were tested with sensitive skin types specifically in mind, consistent with the fragrance-free, minimal-formulation principles for sensitive skin discussed extensively throughout this literature.

Frequently Asked Questions

What makes CIRÈLL different from other moisturizers?

CIRÈLL works through the Biomimetic TriBarrier System, combining ceramide NP/AP/EOS, cholesterol, and essential fatty acids at a physiological 1:1:1 molar ratio that directly reflects the stratum corneum's own natural lipid matrix, rather than relying on water and a single emollient type.

How many times a day should CIRÈLL be used?

As a general rule, twice daily, morning and evening; a third application after handwashing or showering may be reasonable for very dry, atopic, or significantly barrier-compromised skin, using approximately a pea-sized amount per application.

Can CIRÈLL be used together with retinol or AHA/BHA?

Yes, using a 'sandwiching' technique — a thin layer of barrier cream, then the active, then another thin layer of barrier cream — rather than combining them in the same layer, which can help reduce irritation risk.

References

  1. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-1072.
  2. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183-200.
  3. Lodén M. Effect of moisturizers on epidermal barrier function. Clin Dermatol. 2012;30(3):286-296.
  4. Reinhardt TA, Lippolis JD, Nonnecke BJ, Sacco RE. Bovine milk exosome proteome. J Proteomics. 2012;75(5):1486-1492.
  5. van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta. 2014;1841(3):295-313.
  6. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009;9(5):437-446.
  7. Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci. 2008;30(2):87-95.

Further Reading

Back to blog

Leave a comment